European Archives - Page 978 of 1109 - European Medical Journal

An interview with Doctor Evangelos Liatsikos at the 2016 EAU Congress

An interview with Doctor Evangelos Liatsikos (University of Patras, Patras, Greece) at the 2016 European Association of Urology Congress, Munich, Germany.

An interview with Doctor Murat Arslan at the 2016 EAU Congress

An interview with Doctor Murat Arslan (Izmir University, Izmir, Turkey) at the 2016 European Association of Urology Congress, Munich, Germany.

Congress Review – EAU 2016

Don’t miss our congress review in our EMJ Urology 4.1 2016 eJournal, available now at…

Breast cancer in Europe: Epidemiology and outcomes

At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Jan-Willem Coebergh, MD, PhD, from…

Defining factors that can predict neoadjuvant chemotherapy response in breast cancer

At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Andrew Evans, MRCP, FRCR, from the…

Genetically determining susceptibility of breast cancer

At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Douglas Easton, PhD, from the…

Surgical considerations after neoadjuvant treatment for breast cancer

At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Isabel Rubio, MD, PhD, from Hospital…

Individualisation of breast cancer therapy

At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Isabel Rubio, MD, PhD, from Hospital…

EMJ

ILC 2016 – Dr. James Freeman

Dr. James Freeman’s press conference on ‘High Sustained Virological Response Rates Using Direct Acting Antiviral Treatment For Hepatitis C, Imported Into…

ILC 2016 – Dr. Stefano Brillanti

Dr. Stefano Brillanti’s press conference on ‘Development of Hepatocellular Carcinoma in HCV Cirrhotic Patients Treated with Direct Acting Antivirals’ at…